2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Adherence, Treatment: new trials by email Literature Review of Adherence, Treatment trials Research Report on Adherence, Treatment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Next Generation Ingestible Sensors for Medication Adherence Measurement Next-generation Reader and ID-Cap System, Truvada for pre-exposure prophylaxis (PrEP), Biktarvy for antiretroviral therapy (ART) - HIV Infection, Adherence, Medication | Phase 3 | Completed | Brigham and Women's Hospital | 15 | 2023-02-06 | 2024-09-25 |
| SmartSteps: A Context-Aware, PrEP Adherence Intervention for Individuals With Substance Use Disorder Descovy or Truvada, ID-Cap System, Beiwe - HIV Infections, Substance Use | Phase 3 | Completed | Brigham and Women's Hospital | 40 | 2022-12-20 | 2026-07-21 |
HIV Infections (2) · Medication Adherence (2) · Treatment Adherence and Compliance (2) · Substance-Related Disorders (1)
Behavior (2) · Blood-Borne Infections (2) · Communicable Diseases (2) · Genital Diseases (2) · Health Behavior (2) · Immune System Diseases (2) · Immunologic Deficiency Syndromes (2) · Infections (2) · Lentivirus Infections (2) · Patient Acceptance of Health Care (2) · Patient Compliance (2) · RNA Virus Infections (2) · Retroviridae Infections (2) · Sexually Transmitted Diseases (2) · Sexually Transmitted Diseases, Viral (2)
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (2) · Drug Delivery Systems (1) · Pre-Exposure Prophylaxis (1) · bictegravir, emtricitabine, tenofovir alafenamide, drug combination (1) · emtricitabine tenofovir alafenamide (1)
Brigham and Women's Hospital (2)
United States (2)
Peter Chai, MD, MMS (1) · Peter R Chai, MD MMS (1)
DP2DA056107 (1)